Who owns the ONCOLIPIN trademark?

The ONCOLIPIN trademark is owned by XEME Biopharma, Inc..

What class is the ONCOLIPIN trademark registered in?

The ONCOLIPIN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ONCOLIPIN?

The USPTO serial number for ONCOLIPIN is 90611009.

What is the registration number for ONCOLIPIN?

ONCOLIPIN is registered under USPTO registration number 0.

Sealvo

Home Search: ONCOLIPINONCOLIPIN #90611009

Back

Updated Oct 25, 2026·17 searches this week

View on USPTO TSDR Find similar marks

ONC

USPTO Trademark Record

ABANDONED

ONCOLIPIN

SN 90611009·Reg 0·Filed Mar 29, 2021

Owner XEME Biopharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ONCOLIPIN (Serial No. 90611009), Registration No. 0, is a abandoned US trademark filed on Mar 29, 2021 by XEME Biopharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

ONCOLIPIN (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 29, 2021

SERIAL

90611009

REG#

Filing Information

StatusABANDONED

Filing DateMar 29, 2021

Serial Number90611009

Registration No.0

Status DateOct 09, 2025

Published for OppositionDec 21, 2021

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

ABANDONMENT - NO USE STATEMENT FILED

Oct 09, 2025

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 09, 2025

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

SOU TEAS EXTENSION RECEIVED

Aug 14, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Aug 14, 2024

SOU EXTENSION 5 FILED

SOU EXTENSION 5 GRANTED

Aug 14, 2024

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 14, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 16, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 15, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Feb 15, 2024

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Feb 15, 2024

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 17, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 15, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Aug 15, 2023

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Aug 15, 2023

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 17, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 15, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Feb 15, 2023

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Feb 15, 2023

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 17, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 15, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Aug 15, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Aug 15, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 15, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 21, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 21, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 01, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 12, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 05, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 06, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 01, 2021

NEW APPLICATION ENTERED

Other Marks by XEME Biopharma, Inc.

Additional USPTO filings from the same owner.

AGG

AGGREGON

90611005

XEME Biopharma, Inc.

ABANDONED

AGG

AGGREGON

85574345

Xeme Biopharma, Inc.

ABANDONED

AGG

AGGREGON

78647916

Xeme Biopharma, Inc.

ABANDONED

Other Marks by Richard S. Stockton

Additional USPTO filings handled by the same attorney of record.

PAR

PARTS SPECIALIST. SOLUTIONS DRIVEN.

86700109

REGISTERED

BRI

BRIC

86938936

REGISTERED

CHI

CHIEF ENTERPRISES

86639404

REGISTERED

NEU

NEUROLIFE

87641920

REGISTERED

ONCOLIPIN

Run a conflict check

Other Marks by XEME Biopharma, Inc.

Other Marks by Richard S. Stockton

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company